150 related articles for article (PubMed ID: 20032201)
1. Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state.
Foo KS; Brauner H; Ostenson CG; Broberger C
J Endocrinol; 2010 Mar; 204(3):255-63. PubMed ID: 20032201
[TBL] [Abstract][Full Text] [Related]
2. Ontogenic pattern of nucleobindin-2/nesfatin-1 expression in the gastroenteropancreatic tissues and serum of Sprague Dawley rats.
Mohan H; Unniappan S
Regul Pept; 2012 Apr; 175(1-3):61-9. PubMed ID: 22387700
[TBL] [Abstract][Full Text] [Related]
3. Nesfatin-1 stimulates glucagon and insulin secretion and beta cell NUCB2 is reduced in human type 2 diabetic subjects.
Riva M; Nitert MD; Voss U; Sathanoori R; Lindqvist A; Ling C; Wierup N
Cell Tissue Res; 2011 Dec; 346(3):393-405. PubMed ID: 22108805
[TBL] [Abstract][Full Text] [Related]
4. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS.
Foo KS; Brismar H; Broberger C
Neuroscience; 2008 Oct; 156(3):563-79. PubMed ID: 18761059
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin, ghrelin-O-acyl transferase, nucleobindin-2/nesfatin-1 and prohormone convertases in the pancreatic islets of Sprague Dawley rats during development.
Mohan H; Gasner M; Ramesh N; Unniappan S
J Mol Histol; 2016 Jun; 47(3):325-36. PubMed ID: 27071923
[TBL] [Abstract][Full Text] [Related]
6. Expression of nucleobindin 1 (NUCB1) in pancreatic islets and other endocrine tissues.
Williams P; Tulke S; Ilegems E; Berggren PO; Broberger C
Cell Tissue Res; 2014 Nov; 358(2):331-42. PubMed ID: 25038744
[TBL] [Abstract][Full Text] [Related]
7. Increased amounts of a high molecular weight insulin-like growth factor II (IGF-II) peptide and IGF-II messenger ribonucleic acid in pancreatic islets of diabetic Goto-Kakizaki rats.
Höög A; Sandberg-Nordqvist AC; Abdel-Halim SM; Carlsson-Skwirut C; Guenifi A; Tally M; Ostenson CG; Falkmer S; Sara VR; Efendić S; Schalling M; Grimelius L
Endocrinology; 1996 Jun; 137(6):2415-23. PubMed ID: 8641194
[TBL] [Abstract][Full Text] [Related]
8. Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet β- and MIN6 cells.
Gonzalez R; Reingold BK; Gao X; Gaidhu MP; Tsushima RG; Unniappan S
J Endocrinol; 2011 Mar; 208(3):R9-R16. PubMed ID: 21224288
[TBL] [Abstract][Full Text] [Related]
9. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
[TBL] [Abstract][Full Text] [Related]
10. Expression of NUCB2/nesfatin-1 in the taste buds of rats.
Cao X; Zhou X; Cao Y; Liu XM; Zhou LH
Endocr J; 2016; 63(1):37-45. PubMed ID: 26522144
[TBL] [Abstract][Full Text] [Related]
11. Identification of nesfatin-1 as a satiety molecule in the hypothalamus.
Oh-I S; Shimizu H; Satoh T; Okada S; Adachi S; Inoue K; Eguchi H; Yamamoto M; Imaki T; Hashimoto K; Tsuchiya T; Monden T; Horiguchi K; Yamada M; Mori M
Nature; 2006 Oct; 443(7112):709-12. PubMed ID: 17036007
[TBL] [Abstract][Full Text] [Related]
12. Cellular distribution, regulated expression, and functional role of the anorexigenic peptide, NUCB2/nesfatin-1, in the testis.
García-Galiano D; Pineda R; Ilhan T; Castellano JM; Ruiz-Pino F; Sánchez-Garrido MA; Vazquez MJ; Sangiao-Alvarellos S; Romero-Ruiz A; Pinilla L; Diéguez C; Gaytán F; Tena-Sempere M
Endocrinology; 2012 Apr; 153(4):1959-71. PubMed ID: 22334726
[TBL] [Abstract][Full Text] [Related]
13. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity.
Ghanaat-Pour H; Sjöholm A
Diabetes Metab Res Rev; 2009 Feb; 25(2):163-84. PubMed ID: 19065603
[TBL] [Abstract][Full Text] [Related]
14. Nesfatin-1 suppresses energy intake, co-localises ghrelin in the brain and gut, and alters ghrelin, cholecystokinin and orexin mRNA expression in goldfish.
Kerbel B; Unniappan S
J Neuroendocrinol; 2012 Feb; 24(2):366-77. PubMed ID: 22023656
[TBL] [Abstract][Full Text] [Related]
15. Beta-cell mass depletion precedes the onset of hyperglycaemia in the GK rat, a genetic model of non-insulin-dependent diabetes mellitus.
Movassat J; Saulnier C; Portha B
Diabete Metab; 1995 Dec; 21(5):365-70. PubMed ID: 8586154
[TBL] [Abstract][Full Text] [Related]
16. Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat.
Movassat J; Saulnier C; Serradas P; Portha B
Diabetologia; 1997 Aug; 40(8):916-25. PubMed ID: 9267986
[TBL] [Abstract][Full Text] [Related]
17. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
[TBL] [Abstract][Full Text] [Related]
18. Role of NUCB2/nesfatin-1 in glucose control: diverse functions in islets, adipocytes and brain.
Nakata M; Yada T
Curr Pharm Des; 2013; 19(39):6960-5. PubMed ID: 23537085
[TBL] [Abstract][Full Text] [Related]
19. [Effects of severe hyperglycaemia in pregnancy and early overfeeding on islet development and insulin resistance].
Zeng CJ; Zhang L; Yang HX
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):658-63. PubMed ID: 21092544
[TBL] [Abstract][Full Text] [Related]
20. Expression of nesfatin-1/NUCB2 in rodent digestive system.
Zhang AQ; Li XL; Jiang CY; Lin L; Shi RH; Chen JD; Oomura Y
World J Gastroenterol; 2010 Apr; 16(14):1735-41. PubMed ID: 20380005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
